Takeda Pharmaceutical Shares Outstanding 2010-2024 | TAK

Takeda Pharmaceutical shares outstanding for the quarter ending December 31, 2024 were 0M, a 100% decline year-over-year.

  • Takeda Pharmaceutical 2025 shares outstanding were 3.158B, a 0.09% decline from 2024.
  • Takeda Pharmaceutical 2024 shares outstanding were 3.161B, a 0.67% increase from 2023.
  • Takeda Pharmaceutical 2023 shares outstanding were 3.14B, a 0.46% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Takeda Pharmaceutical Shares Outstanding 2010-2024 | TAK

  • Takeda Pharmaceutical 2025 shares outstanding were 3.158B, a 0.09% decline from 2024.
  • Takeda Pharmaceutical 2024 shares outstanding were 3.161B, a 0.67% increase from 2023.
  • Takeda Pharmaceutical 2023 shares outstanding were 3.14B, a 0.46% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$95B
Zoetis (ZTS)$66.3B
Daiichi Sankyo, - (DSNKY)$41.7B
Summit Therapeutics (SMMT)$18.2B
Sandoz Group AG (SDZNY)$17.7B
Merck (MKKGY)$17.2B
Astellas Pharma (ALPMY)$16.9B
Shionogi (SGIOY)$14.1B
United Therapeutics (UTHR)$12.8B
Neurocrine Biosciences (NBIX)$10B
IPSEN (IPSEY)$8.6B
Orion OYJ (ORINY)$8B
Madrigal Pharmaceuticals (MDGL)$6.7B
Stevanato Group S.p.A (STVN)$6.6B
Corcept Therapeutics (CORT)$6.6B
Hikma Pharmaceuticals Plc (HKMPF)$5.8B
Ono Pharmaceutical (OPHLF)$5.5B
Grifols, S.A (GRFS)$4.9B
Ionis Pharmaceuticals (IONS)$4.5B
Soleno Therapeutics (SLNO)$3.2B
Crinetics Pharmaceuticals (CRNX)$2.8B
Catalyst Pharmaceuticals (CPRX)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.3B
Recursion Pharmaceuticals (RXRX)$2.2B
Hypermarcas (HYPMY)$2.1B
NewAmsterdam Pharma (NAMS)$1.8B
Centessa Pharmaceuticals (CNTA)$1.6B
BioCryst Pharmaceuticals (BCRX)$1.5B
Guardian Pharmacy Services (GRDN)$1.5B
ARS Pharmaceuticals (SPRY)$1.5B